Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTUITIVE SURGICAL INC Director's Dealing 2021

Apr 28, 2021

29809_dirs_2021-04-27_e0833f93-b874-4201-aea6-b737d4b09f7b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2021-04-26

Reporting Person: MOHR MARSHALL (Executive VP & CFO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-04-26 Common Stock M 9375 $153.0467 Acquired 9375 Direct
2021-04-26 Common Stock S 9375 $865.6341 Disposed 0 Direct
2021-04-26 Common Stock M 21000 $172.4367 Acquired 21000 Direct
2021-04-26 Common Stock S 12588 $865.7374 Disposed 8412 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-04-26 Non-Qualified Stock Option (right to buy) $153.0467 M 9375 Disposed 2024-08-15 Common Stock (9375) Direct
2021-04-26 Non-Qualified Stock Option (right to buy) $172.4367 M 21000 Disposed 2022-08-15 Common Stock (21000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 23492 Indirect

Footnotes

F1: These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 2, 2021.

F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $860.174 to $870.00,inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $861.74 to $870.046,inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.